Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Vanishing white matter (VWM) disease (OMIM#306896) is an autosomal recessive neurodegenerative leukodystrophy caused by hypomorphic mutations in any of the five genes encoding the subunits of eukaryotic translation initiation factor 2B (eIF2B).
|
31134486 |
2019 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Vanishing white matter disease (VWM; MIM #603896), also known as childhood ataxia with central nervous system hypomyelination (CACH) syndrome, is an autosomal recessive transmitted leukoencephalopathy related to mutations in each of the 5 genes (EIF2B1, EIF2B2, EIF2B3, EIF2B4 and EIF2B5) encoding for the 5 subunits of eukaryotic translation initiation factor 2B (eIF2B), essential for protein synthesis.
|
16998732 |
2006 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Vanishing white matter disease (VWM) is an autosomal recessive neurological disorder caused by mutation(s) in any subunit of eukaryotic translation initiation factor 2B (eIF2B), an activator of translation initiation factor eIF2.
|
31587290 |
2019 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
Biomarker
|
disease |
BEFREE |
Vanishing white matter disease (VWM) is a progressive cavitating disease of central white matter due to a deficiency of the translation initiation factor eIF2B.
|
15217090 |
2004 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in eIF2B have also recently been found to cause a fatal human disease called CACH (childhood ataxia with central nervous system hypomyelination) or VWM (vanishing white matter disease).
|
16246152 |
2005 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A unique EIF2B mutation spectrum in Chinese VWM patients was shown.
|
19158808 |
2009 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
Biomarker
|
disease |
BEFREE |
A yeast purification system for human translation initiation factors eIF2 and eIF2Bε and their use in the diagnosis of CACH/VWM disease.
|
23335982 |
2013 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter.
|
11835386 |
2002 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In seven patients, we report for the first time mutations in three of the five EIF2B genes (EIF2B2, -4, and -5) that were recently shown to cause childhood ataxia with central nervous system hypomyelination/vanishing white-matter disease leukodystrophy.
|
12707859 |
2003 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
Biomarker
|
disease |
BEFREE |
Further dissection of the signaling network associated with eIF2B function will help generating therapeutic strategies for VWM disease and possibly other neurodegenerative disorders.
|
28306143 |
2017 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
EIF2B1-5 genes encoding five subunits of eukaryotic translation initiation factor 2B (eIF2B) were analyzed in all patients with clinically suspected VWM disease.
|
31385086 |
2020 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in each of the five eucaryotic initiation factor 2B (eIF2B) subunits have been found in leukodystrophies of various severity: Cree leukoencephalopathy, childhood ataxia with central hypomyelination/leukodystrophy with vanishing white matter and ovarioleukodystrophy.
|
15054402 |
2004 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Vanishing white matter (VWM) disease is an autosomal genetic leukodystrophy caused by mutations in subunits of eukaryotic translation initiation factor 2B (eIF2B).
|
30279648 |
2018 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The genes encoding all five subunits of eukaryotic translation initiation factor 2B (EIF2B) were analyzed in patients, who were tentatively diagnosed with VWM, by Sanger sequencing.
|
25843247 |
2015 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our findings imply CACH/VWM mutations do not specifically impair responses to eIF2 phosphorylation, but instead cause protein structure defects that impair eIF2B activity.
|
14993275 |
2004 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Leukoencephalopathy with vanishing white matter (VWM), also called childhood ataxia with central nervous system hypomyelination (CACH), is an autosomal recessive disease caused by mutations in any of the five genes encoding subunits of the eukaryotic translation initiation factor eIF2B.
|
16823698 |
2006 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The typical MRI pattern with a diffuse CSF-like aspect of the cerebral white matter can lack particularly in the adult forms whereas an increasing number of patients with clinical and MRI criteria for CACH/VWM disease but without eIF2B mutations are found.
|
20016818 |
2009 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Vanishing white matter disease (VWM) is an inherited leukoencephalopathy in children attributed to mutations in EIF2B1-5, encoding five subunits of eukaryotic translation initiation factor 2B (eIF2B).
|
30720246 |
2019 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.
|
11704758 |
2001 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Efficient detection of frequent eIF2B mutations for the rapid molecular diagnosis of CACH/VWM syndrome.
|
26162493 |
2015 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.100 |
Biomarker
|
disease |
BEFREE |
There is sufficient evidence suggesting role of eukaryotic translation initiation factor 2B (EIF2B) gene family encoding the five subunits of eIF2B complex-α, β, γ, δ and ε respectively, in causing vanishing white matter (VWM) disease of the brain.
|
28093708 |
2017 |
Cirrhosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Eukaryotic protein translation and recycling of eIF2:GDP related SNP variants were associated with ballooning, steatohepatitis and cirrhosis.
|
23894275 |
2013 |
Cognition Disorders
|
0.010 |
PosttranslationalModification
|
group |
BEFREE |
ISRIB, a drug-like eIF2B activator, reverses the effects of eIF2 phosphorylation, and in rodents it enhances cognition and corrects cognitive deficits after brain injury.
|
29599213 |
2018 |
Colorectal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Bioinformatics analyses reveal that compared to control samples, the immunoproteomic IgG profiling of CRC samples is mainly associated with cell death, survival, and proliferation pathways, especially proteins involved in EIF2 and mTOR signaling.
|
29505855 |
2018 |
Complete Trisomy 21 Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Genetic and pharmacological suppression of the ISR, by inhibiting the ISR-inducing double-stranded RNA-activated protein kinase or boosting the function of the eukaryotic translation initiation factor eIF2-eIF2B complex, reversed the changes in translation and inhibitory synaptic transmission and rescued the synaptic plasticity and long-term memory deficits in DS mice.
|
31727829 |
2019 |